Michelle Ross
Chief Investment Officer at StemPoint Capital and biotech fund manager, speaking about recent biotech catalysts, breakout names and investment opportunities in small- and mid-cap biotech.
Best podcasts with Michelle Ross
Ranked by the Snipd community
Oct 6, 2025 • 43min
Closing Bell: Is AI Artificially Inflated? 10/6/25
Michelle Ross, Chief Investment Officer at StemPoint Capital and a savvy biotech fund manager, dives into the world of small- and mid-cap biotech opportunities. She discusses the catalysts behind biotech's recent rally, like new policy signals and lucrative M&A activities. Ross also breaks down the impressive data results from Unicure's gene therapy and highlights which biotech stocks, such as Abivax and ScholarRock, show promising upside. Her insights reveal why these companies could be the next big winners in the biotech space.
May 9, 2025 • 43min
Closing Bell: Stocks Waver Ahead of China Talks 5/9/25
Michelle Ross, CIO of StemPoint Capital and expert in biotech investments, shares insights on the evolving healthcare landscape. She tackles the complexities of drug pricing in the U.S., balancing innovation with affordability. The discussion highlights potential regulatory changes affecting investor sentiment and market dynamics. Ross also explores exciting investment opportunities in rare diseases and oncology firms while examining the impact of upcoming FDA approvals on stock performance.
